Advocacy • Engagement • Empowerment • Change

Pharmaceutical and biotech companies are getting more in tune with patient engagement every day and therefore trying to incorporate the voice and perspective of the patient in their initiatives – from product development to marketing initiatives – to better understand the patient and "answer the call" of advocacy organizations.

Top Reasons to Attend:

• Gain insight of changes in legislation and how pharma is affected
• Hear from thought leaders representing a variety of advocacy perspectives
• Participate in a hands-on workshop to develop an effective advocacy team
• Discover metrics to measure the value of advocacy teams
• Learn to address e-patient concerns while maintaining proper transparency

Confirmed Speakers

Carrie Burke Director, Alliance Development Shire Pharmaceuticals	Geraldine Carroll Associate Director, Advocacy Relations Biogen Idec	Susan E. King Director, Advocacy Pharmacyclics, Inc
Kelly Kunik e-Patient, Diabetes Author, Diabetesaliciousness	Amye L. Leong, MBA President and Chief Executive Officer, Healt hy Motivat ion Spokesperson and Director of Strategic Relations United Nations Bone & Joint Decade, the Global Alliance for Musculoskeletal Health	Amy O’Connor Director, Digital Government Affairs Campaign for Modern Medicines Eli Lilly and Company
Robert Popovian, PharmD, MS Senior Director, Advocacy and Professional Relations US Government Relations Pfizer Inc	John Rother CEO National Coalition on Health Care	Molly Ryan Director, Government Affairs and Advocacy Otuska America Pharmaceutical Inc.
Aliza Tomlinson CNS / PAIN Advocacy Director Strategic Customer Group Johnson & Johnson	William J. Tunno Director, Global Patient Advocacy & Professional Relations Boehringer Ingelheim Pharmaceuticals, Inc.